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IMPORTANCE The comparative diagnostic performance of dermoscopic algorithms and their
individual criteria are not well studied.
OBJECTIVES To analyze the discriminatory power and reliability of dermoscopic criteria used
in melanoma detection and compare the diagnostic accuracy of existing algorithms.
DESIGN, SETTING, AND PARTICIPANTS This was a retrospective, observational study of 477
lesions (119 melanomas [24.9%] and 358 nevi [75.1%]), which were divided into 12 image sets
that consisted of 39 or 40 images per set. A link on the International Dermoscopy Society
website from January 1, 2011, through December 31, 2011, directed participants to the study
website. Data analysis was performed from June 1, 2013, throughMay 31, 2015. Participants
included physicians, residents, andmedical students, and there were no specialty-type or
experience-level restrictions. Participants were randomly assigned to evaluate 1 of the 12
image sets.
MAIN OUTCOMES ANDMEASURES Associations withmelanoma and intraclass correlation
coefficients (ICCs) were evaluated for the presence of dermoscopic criteria. Diagnostic
accuracy measures were estimated for the following algorithms: the ABCD rule, the Menzies
method, the 7-point checklist, the 3-point checklist, chaos and clues, and CASH (color,
architecture, symmetry, and homogeneity).
RESULTS A total of 240 participants registered, and 103 (42.9%) evaluated all images. The
110 participants (45.8%) who evaluated fewer than 20 lesions were excluded, resulting in
data from 130 participants (54.2%), 121 (93.1%) of whomwere regular dermoscopy users.
Criteria associated with melanoma includedmarked architectural disorder (odds ratio [OR],
6.6; 95% CI, 5.6-7.8), pattern asymmetry (OR, 4.9; 95% CI, 4.1-5.8), nonorganized pattern
(OR, 3.3; 95% CI, 2.9-3.7), border score of 6 (OR, 3.3; 95% CI, 2.5-4.3), and contour
asymmetry (OR, 3.2; 95% CI, 2.7-3.7) (P < .001 for all). Most dermoscopic criteria had poor to
fair interobserver agreement. Criteria that reachedmoderate levels of agreement included
comma vessels (ICC, 0.44; 95% CI, 0.40-0.49), absence of vessels (ICC, 0.46; 95% CI,
0.42-0.51), dark brown color (ICC, 0.40; 95% CI, 0.35-0.44), and architectural disorder (ICC,
0.43; 95% CI, 0.39-0.48). TheMenzies method had the highest sensitivity for melanoma
diagnosis (95.1%) but the lowest specificity (24.8%) compared with any other method
(P < .001). The ABCD rule had the highest specificity (59.4%). All methods had similar areas
under the receiver operating characteristic curves.
CONCLUSIONS AND RELEVANCE Important dermoscopic criteria for melanoma recognition
were revalidated by participants with varied experience. Six algorithms tested had similar but
modest levels of diagnostic accuracy, and the interobserver agreement of most individual
criteria was poor.
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U seofdermoscopybytrainedusers,butnotnovices, im-proves diagnostic accuracy for cutaneous melanomacompared with naked eye examination alone.1 Ex-
perts of dermoscopy tend to reviewadermoscopic image and
reach a diagnosis without use of structured analytical crite-
ria, adiagnosticprocess that canbe referred toaspatternanaly-
sis. Multiple simplified dermoscopic algorithms, such as the
ABCD rule, the Menzies method, the 7-point checklist, the
3-point checklist, chaos and clues, and CASH (color, architec-
ture, symmetry, and homogeneity), were developed to facili-
tate anovice’s ability todistinguishmelanomas fromneviwith
high diagnostic accuracy.2-7 A comparison of these algo-
rithms reveals 2 diverging approaches to simplified mela-
noma detection (Table 1). The ABCD rule and CASH princi-
pally quantify theoverall organizationof a lesionby assessing
features such as symmetry, architectural disorder, border
sharpness, and heterogeneity in colors and structures. How-
ever, the 7-point checklist relies on the identificationof atypi-
cal appearances of dermoscopic structures (eg, atypical net-
work) indistinction fromotherwisenormal counterparts oron
identifying unique structures strongly associated with mela-
noma (eg, regression). Chaos and clues, theMenziesmethod,
and the3-point checklist includeelementsofbothapproaches.
Although each algorithm has unique criteria, there is
significant overlap in their concepts, whichmay explain why
the ABCD rule, the Menzies method, and the 7-point check-
list have similar overall accuracy in the diagnosis of melano-
cytic lesions by novices.8 Beginners and instructors of
dermoscopy are consequently unclear as to which, if any, al-
gorithm(s) they should use and teach, respectively. In addi-
tion, no algorithm has been significantly revised since its ini-
tial publication to include newly identified dermoscopic
featureswith high specificity formelanoma, such as negative
network orwhite shiny structures.9,10 A critical need exists to
better understand the comparativediagnostic performanceof
dermoscopicalgorithms, inparticular thediscriminatorypower
and interobserver agreement of their individual criteria. The
primary objective of this study was to measure the discrimi-
natory power and interobserver agreement of individual der-
moscopic criteria, includingnewlydescribeddermoscopic fea-
tures. A secondary objective was to compare the diagnostic
accuracy of 6 existing simplified algorithms.
Methods
TheMemorial SloanKetteringCancer Center Institutional Re-
view Board approved this study without the requirement for
written informed consent in accordance with the Helsinki
Declaration. Data were deidentified.
Lesion Selection
Twelve pigmented lesion clinics fromAustralia, Austria, Ger-
many, Italy, Spain, Switzerland, and theUnitedStates contrib-
uted study images. Each contributor provided up to 50 le-
sions with a 1:3 ratio of melanomas to nevi. Melanomas were
requiredtohaveanunequivocalhistopathologicdiagnosis, and
Key Points
Question What is the discriminatory power and reliability of
dermoscopic criteria used in melanoma detection?
Findings In this survey-based study, the diagnostic importance of
new and previously identified dermoscopic criteria for melanoma
detection was validated; however, the majority of criteria had poor
to fair interobserver agreement. Criteria with relatively strong
discriminatory power andmoderate levels of interobserver
agreement included architectural disorder, pattern asymmetry,
contour asymmetry, comma vessels, and absence of vessels.
Meaning Further efforts are needed to standardize terminology
and definitions of dermoscopic criteria.
Table 1. Comparison of Dermoscopic Criteria of Simplified Diagnostic Algorithms forMelanoma
Criterion ABCD Rule CASH Menzies Method 7-Point Checklist 3-Point Checklist Chaos and Clues
Symmetry in colors or
structures
    
Border sharpness 
Quantity of specified colors   
Quantity of specified
structures
a b
Architectural disorder 
Blue-white veil    
Any blue or white color  
Atypical dots or globules   
Regression    
Streaks   
Atypical network    
Atypical vessels  
Irregular blotch  
Abbreviation: CASH, color, architecture, symmetry, and homogeneity.
a The ABCD rule includes dots, globules, structureless areas, network, and
streaks and does not distinguish between atypical and typical structures.
b CASH includes dots or globules, blotches, network, regression, streaks,
blue-white veil, and polymorphous vessels and does not distinguish between
atypical and typical structures.
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neviwere required tobehistopathologicallyverifiedor tohave
demonstrated stabilityunder sequential dermoscopic imaging
over time. Contributors sequentially selected lesions from
their patient records and used 1:1 randomization of lesions
into polarized vs nonpolarized sets. Other requested data
included anatomical location, patient age and sex, imaging
modality (polarized vs nonpolarized), and a clinical close-up
image.
A total of 580 lesions (140melanomas and440nevi)were
contributed to the study. Lesionswere reviewedbyMemorial
SloanKetteringCancer Center investigators, and 103were ex-
cludedbecauseof (1) locationonacral,mucosal, or facial sites,
(2) inadequate image quality, (3) equivocal diagnosis after
reviewof thepathology report or sequential imaging, (4) non-
melanocytic lesions, and (5) lesions frompatientsyounger than
18 years. The final data set was composed of 477 unique le-
sions,ofwhich119 (24.9%)weremelanomas.Lesionswere ran-
domized into 12 image sets that contained 39 (n = 8) or 40
(n = 7) unique lesions and5nonunique lesion images (2mela-
noma, 3 benign) that were repeated in all sets.
Web-Based Study Interface
Algorithm tutorials were created and posted by dermoscopic
experts through the International Dermoscopy Society (IDS)
website. Review of tutorials was encouraged but not manda-
tory for participants, and links to tutorials were available on
the main study site interface and the data collection form.
Participant Selection
A linkpresenton the IDSwebsite fromJanuary 1, 2011, through
December 31, 2011, directed participants to the studywebsite
(www.dermoscopy-ids.org).Dataanalysiswasperformedfrom
June 1, 2013, throughMay 31, 2015. Participationwas open to
attendingphysicians, residents, andmedical students andwas
not restricted by specialty type or experience level. Image
contributorswere excluded from the study. Participantswere
required to register andspecify their specialty, years of clinical
experience, preferred dermoscopic analysis method,
dermoscopy frequency of use, predominant modality
(polarizedvsnonpolarized) of use, andexperience. Therewas
no incentive for study participation.
Two hundred forty participants registered for the study,
and 103 (42.9%) completed all available images in their data
sets. The 110 participants (45.8%) who evaluated fewer than
20 lesionswere excluded, resulting in data from a total of 130
participants (54.2%) eligible for analysis.
Participant Evaluation
A comprehensive list of all dermoscopic structures from the
dermoscopy algorithms was created, and overlapping crite-
ria were merged into 1 criterion (eg, granularity and pepper-
ing were combined into 1 criterion). Newly identified dermo-
scopic structures with high specificity for melanoma
(eg,negativenetwork, chrysalis structures [shinywhiteorcrys-
tallinestructures],polymorphousvessels, atypicalvessels, and
pink veil) were included. Criteria included (1) global pattern,
(2) patternorganization, (3) symmetry of contour, (4) symme-
try of pattern, (5) architectural disorder, (6) abruptness of
lesion border, (7) colors, and (8) melanocytic structures, in-
cluding network and vascular structures. Participants exam-
ined the close-up clinical image of each lesion before viewing
thedermoscopic image. Themodality (polarizedvsnonpolar-
ized)ofdermoscopic imageswasspecified.Therewereno time
constraints. For each lesion, the participant indicated the
presence or absence of all dermoscopic criteria on the same
webpage. Users were unable to modify their responses for a
lesion after submission of data.
Statistical Analysis
Descriptive statistics and graphic methods were used to de-
scribeparticipantandlesioncharacteristicsandparticipantder-
moscopic evaluations because block randomizationwasused
and no participants evaluated all images. Data were assessed
as individual dermoscopic evaluations and as consensus
evaluations for participants who reviewed a given study
lesion. For individual evaluations, prevalence of each der-
moscopic feature was tabulated along with 95% CIs. To
quantify the association for the presence or absence of each
feature with melanoma status, tabular cross-classifications,
χ2 statistics, and the associated odds ratios (ORs) and 95%
CIs were calculated. Robust SEs were estimated to adjust for
the clustered observations within reviewers. Intraclass cor-
relation coefficients (ICCs) were estimated for each dermo-
scopic feature using 2-way random-effects models, with
the dermoscopic raters treated as a random effect. This
approach assumes that raters are randomly sampled from
the larger population of raters with dermoscopic experience.
The ICC is equal to 0 when the agreement is exactly what is
expected by chance and 1 when there is perfect agreement.
Intermediate values were interpreted as follows: poor, 0.01
to less than 0.2; fair, 0.2 to less than 0.4; moderate, 0.4 to
less than 0.6; substantial, 0.6 to less than 0.8; and almost
perfect agreement, greater than 0.8.
Forconsensusevaluations, thepresenceorabsenceofeach
dermoscopic feature was calculated as the proportion of par-
ticipants who identified the feature for a given lesion. When
50%ormore of the participants identified a dermoscopic fea-
ture for a given study lesion, the attributewas consideredpre-
sent.We applied consensus evaluations to dermoscopic algo-
rithms to evaluate performance. Using logistic regression
models with the dichotomous outcome of melanoma vs ne-
vus, we compared areas under the receiver operating charac-
teristic (ROC) curve among the diagnostic algorithms. Analy-
ses were performed with STATA statistical software, version
12.1 (StataCorp).
Results
Participants
The 130 participants who evaluated 20 lesions or more had a
mean (SD) of 12 (8.7) years of dermatology experience. The
mean (SD) percentages of their practice thatwas composedof
skin cancer screening and the population at high risk for skin
cancerwere 33.5% (25.8%) and 14.4% (16.4%), respectively. A
total of 73 participants (56.2%) reported being attending
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dermatologists, 122 (93.8%) were comfortable using dermos-
copy, and 121 (93.1%) were regular users of dermoscopy
(Table 2).
Lesion Evaluations
Atotal of 477unique lesionswere evaluated in the study.Each
lesion was evaluated by amedian of 12 participants, with the
exception of the 5 lesions that were repeated in the 12 image
sets and evaluated by all 130 participants, resulting in a total
of 5670 unique lesion evaluations.
Interobserver Agreement of Dermoscopic Criteria
Mostdermoscopic criteriahadpoor to fair interobserver agree-
ment, including features such as atypical network (ICC, 0.21;
95% CI, 0.17-0.25), blue-white veil (ICC, 0.34; 95% CI, 0.30-
0.39), regression (ICC, 0.11; 95% CI, 0.08-0.13), and atypical
vessels (ICC, 0.26; 95% CI, 0.22-0.30) (Table 3).
Criteria with moderate levels of interobserver agree-
ment included comma vessels (ICC, 0.44; 95% CI, 0.40-
0.49), absence of vessels (ICC, 0.46; 95% CI, 0.42-0.51),
dark brown color (ICC, 0.40; 95% CI, 0.35-0.44), and archi-
tectural disorder (ICC, 0.43; 95% CI, 0.39-0.48) (Table 3).
Absence of network (ICC, 0.39; 95% CI, 0.34-0.43), pattern
symmetry (ICC, 0.37; 95% CI, 0.32-0.41), contour symmetry
(ICC, 0.37; 95% CI, 0.32-0.42), and total colors present (ICC,
0.36; 95% CI, 0.31-0.40) had similar levels of interobserver
agreement.
Dermoscopic Criteria AssociatedWithMelanoma Status
Criteria strongly associated with melanoma status (OR ≥3)
included marked architectural disorder (OR, 6.6; 95% CI,
5.6-7.8), pattern asymmetry (OR, 4.9; 95% CI, 4.1-5.8), non-
organized pattern (OR, 3.3; 95% CI, 2.9-3.7), border score of
6 (OR, 3.3; 95% CI, 2.5-4.3), contour asymmetry (OR, 3.2;
95% CI, 2.7-3.7), polymorphous vessels (OR, 3.1; 95% CI,
2.4-4.0), border score of 5 (OR, 3.1; 95% CI, 2.3-4.2), and
atypical vessels (OR, 3.0; 95% CI, 2.5-3.6) (P < .001 for all)
(Table 3). Inability to determine features such as border
score (OR, 4.1; 95% CI, 3.1-5.4), pattern symmetry (OR, 6.3;
95% CI, 3.6-10.8), and contour symmetry (OR, 6.3; 95% CI,
4.0-9.9) were also strongly associated with melanoma sta-
tus (all P < .001). Other criteria associated with melanoma
status are given in Table 3.
Criteria with a strong inverse association with mela-
noma status (OR <0.7) included comma vessels (OR, 0.4;
95% CI, 0.3-0.6), peripheral reticular with central hyperpig-
mentation global pattern (OR, 0.5; 95% CI, 0.4-0.6), globu-
lar global pattern (OR, 0.5; 95% CI, 0.4-0.6), 2-component
symmetric global pattern (OR, 0.5; 95% CI, 0.3-0.7), regular
brown dots (OR, 0.5; 95% CI, 0.4-0.6), regular brown glob-
ules (OR, 0.5; 95% CI, 0.4-0.7), absence of vessels (OR, 0.5;
95% CI, 0.4-0.5), regular blotch (OR, 0.4; 95% CI, 0.3-0.6),
and light brown color (OR, 0.6; 95% CI, 0.5-0.7) (all
P < .001) (Table 3).
The dermoscopic criteriawith ICC levels of 0.37 or higher
and relatively strong discriminatory power (OR ≥3.0 or <0.7)
included commavessels, absenceof vessels,markedarchitec-
tural disorder, pattern asymmetry, and contour asymmetry.
Newly Identified Dermoscopic Criteria
Negativenetwork (OR, 1.4; 95%CI, 1.1-1.8;P = .005) andwhite
shiny structures (OR, 2.5; 95% CI, 1.8-3.5; P < .001) were sig-
nificantlyassociatedwithmelanomastatus.However,bothhad
poor interobserver agreement levels (negative network: ICC,
0.15; 95%,CI0.12-0.18;white shiny structures: ICC,0.16; 95%
CI, 0.13-0.19).
Table 2. Participant Characteristics
Characteristic No. (%) (n = 130)
Clinical specialty
Dermatologist 73 (56.2)
General practitioner 24 (18.5)
Dermatology resident 25 (19.2)
Medical student 1 (0.8)
Other 7 (5.4)
Do you regularly use dermoscopy?
No 9 (6.9)
Yes 121 (93.1)
Dermoscopy modality used?
Nonpolarized 41 (31.5)
Polarized 89 (68.5)
Comfortable practicing without dermoscopy?
No 111 (85.4)
Yes 19 (14.6)
Comfortable using dermoscopy?
No 8 (6.2)
Yes 122 (93.8)
Frequency of dermoscopy use?
Almost always 118 (90.8)
Sometimes 5 (3.8)
Rarely 7 (5.4)
What do you use dermoscopy on?
Most lesions 76 (58.5)
Selected lesions 17 (13.1)
Selected lesion plus few more 37 (28.5)
Preferred dermoscopy method?
Pattern analysis 65 (50.0)
ABCD rule 19 (14.6)
7-Point checklist 13 (10.0)
3-Point checklist 10 (7.7)
Menzies method 9 (6.9)
Chaos and clues 6 (4.6)
CASH algorithm 2 (1.5)
Nonselective screening 1 (0.8)
Overall gestalt based on familiarity 1 (0.8)
7-Point checklist and pattern analysis 1 (0.8)
ABCD rule and pattern analysis 1 (0.8)
Do not own a dermoscope 1 (0.8)
No response 1 (0.8)
Do you use photography to follow up patients?
No 22 (16.9)
Yes 108 (83.1)
Abbreviation: CASH, color, architecture, symmetry, and homogeneity.
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Table 3. Association Between Dermoscopic CriteriaWithMelanoma Status
Dermoscopic Criterion
No. (%) of Lesions
OR (95% CI) P Value ICC (95% CI)a
Nevus
(n = 4064)
Melanoma
(n = 1541)
Global pattern
Diffuse reticular: present 720 (17.7) 215 (14.0) 0.8 (0.6-0.9) .001 0.25 (0.21-0.29)
Patchy reticular: present 481 (11.8) 173 (11.2) 0.9 (0.8-1.1) .53 0.17 (0.14-0.20)
Peripheral reticular with central hypopigmentation: present 306 (7.5) 108 (7.0) 0.9 (0.7-1.2) .50 0.32 (0.28-0.37)
Peripheral reticular with central hyperpigmentation: present 481 (11.8) 97 (6.3) 0.5 (0.4-0.6) <.001 0.29 (0.24-0.33)
Peripheral reticular with central globules: present 159 (3.9) 41 (2.7) 0.7 (0.5-1) .02 0.13 (0.10-0.16)
Homogeneous: present 324 (8.0) 126 (8.2) 1.0 (0.8-1.3) .80 0.22 (0.18-0.25)
Peripheral globular: present 168 (4.1) 43 (2.8) 0.7 (0.5-0.9) .02 0.32 (0.28-0.36)
Globular: present 317 (7.8) 60 (3.9) 0.5 (0.4-0.6) <.001 0.28 (0.24-0.32)
Multicomponent: present 157 (3.9) 75 (4.9) 1.3 (1.0-1.7) .09 0.05 (0.03-0.06)
Two-component symmetric: present 166 (4.1) 32 (2.1) 0.5 (0.3-0.7) <.001 0.07 (0.05-0.10)
Other: present 582 (14.3) 411 (26.7) 2.2 (1.9-2.5) <.001 0.13 (0.10-0.16)
Pattern unable to determine: present 203 (5.0) 160 (10.4) 2.2 (1.8-2.7) <.001 0.10 (0.08-0.12)
Organized 0.19 (0.16-0.22)
No 1593 (39.2) 1007 (65.3) 3.3 (2.9-3.7) <.001
Yes 2304 (56.7) 445 (28.9) 1 [Reference] NA
Unknown 165 (4.1) 89 (5.8) 2.8 (2.1-3.7) <.001
Contour symmetry 0.37 (0.32-0.42)
Two axes 1876 (46.2) 398 (25.9) 1 [Reference] NA
One axis 981 (24.2) 313 (20.4) 1.5 (1.3-1.8) <.001
None 1173 (28.9) 788 (51.2) 3.2 (2.7-3.7) <.001
Unable to determine 29 (0.7) 39 (2.5) 6.3 (4.0-9.9) <.001
Pattern symmetry 0.37 (0.32-0.41)
Two axes 1450 (35.7) 189 (12.3) 1 [Reference] NA
One axis 1002 (24.7) 313 (20.4) 2.4 (1.9-3.0) <.001
None 1569 (38.7) 1005 (65.3) 4.9 (4.1-5.8) <.001
Unable to determine 38 (0.9) 31 (2.0) 6.3 (3.6-10.8) <.001
Architectural disorder 0.43 (0.39-0.48)
None 2115 (52.1) 379 (24.6) 1 [Reference] NA
Mild 1435 (35.4) 556 (36.2) 2.2 (1.9-2.5) <.001
Marked 509 (12.5) 603 (39.2) 6.6 (5.6-7.8) <.001
Borders 0.16 (0.13-0.19)
0 2063 (50.8) 486 (31.6) 1 [Reference] NA
NA
1 299 (7.4) 114 (7.4) 1.6 (1.3-2.1) <.001
2 385 (9.5) 165 (10.7) 1.8 (1.5-2.2) <.001
3 300 (7.4) 127 (8.3) 1.8 (1.4-2.3) <.001
4 221 (5.4) 148 (9.6) 2.8 (2.3-3.6) <.001
5 120 (3.0) 88 (5.7) 3.1 (2.3-4.2) <.001
6 130 (3.2) 100 (6.5) 3.3 (2.5-4.3) <.001
7 87 (2.1) 52 (3.4) 2.5 (1.8-3.6) <.001
8 343 (8.5) 151 (9.8) 1.9 (1.5-2.3) <.001
Unable to determine 111 (2.7) 107 (6.9) 4.1 (3.1-5.4) <.001
Colors
Light brown 3677 (90.5) 1307 (84.8) 0.6 (0.5-0.7) <.001 0.28 (0.24-0.32)
Dark brown 3333 (82.0) 1212 (78.7) 0.8 (0.7-0.9) .004 0.40 (0.35-0.44)
White 698 (17.2) 468 (30.4) 2.1 (1.8-2.4) <.001 0.20 (0.16-0.23)
Gray 710 (17.5) 304 (19.7) 1.2 (1.0-1.3) .05 0.10 (0.08-0.13)
Blue 421 (10.4) 291 (18.9) 2.0 (1.7-2.4) <.001 0.21 (0.17-0.24)
Black 938 (23.1) 572 (37.1) 2.0 (1.7-2.2) <.001 0.36 (0.31-0.41)
Red 835 (20.6) 514 (33.4) 1.9 (1.7-2.2) <.001 0.36 (0.31-0.41)
Blue or gray 675 (16.6) 398 (25.8) 1.7 (1.5-2.0) <.001 0.15 (0.12-0.18)
Blue or white 327 (8.1) 238 (15.4) 2.1 (1.7-2.5) <.001 0.17 (0.14-0.21)
(continued)
Research Original Investigation Dermoscopic Criteria Used to Differentiate Nevi FromMelanoma
802 JAMADermatology July 2016 Volume 152, Number 7 (Reprinted) jamadermatology.com
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/derm/935431/ by a Universidad de Barcelona User  on 05/29/2017
Copyright 2016 American Medical Association. All rights reserved.
Table 3. Association Between Dermoscopic CriteriaWithMelanoma Status (continued)
Dermoscopic Criterion
No. (%) of Lesions
OR (95% CI) P Value ICC (95% CI)a
Nevus
(n = 4064)
Melanoma
(n = 1541)
Total colors 1.4 (1.3-1.5) <.001 0.36 (0.31-0.40)
1 340 (8.4) 78 (5.1)
NA NA NA
2 1373 (33.8) 344 (22.3)
3 1344 (33.1) 463 (30.1)
4 678 (16.7) 348 (22.6)
5 229 (5.6) 171 (11.1)
6 68 (1.7) 84 (5.5)
7 21 (0.5) 34 (2.2)
8 6 (0.2) 11 (0.7)
9 4 (0.1) 8 (0.5)
Network
None 1155 (28.4) 496 (32.2) 2.5 (2.1-3.0) <.001 0.39 (0.34-0.43)
Typical 1057 (26.0) 181 (11.8) 1 [Reference] NA 0.19 (0.16-0.23)
Atypical 1560 (38.4) 756 (49.1) 2.8 (2.4-3.4) <.001 0.21 (0.17-0.25)
Both 292 (7.2) 108 (7.0) 2.2 (1.6-2.8) <.001 0.11 (0.08-0.13)
Network
Pseudo: present 161 (4.0) 57 (3.7) 0.9 (0.7-1.3) .65 0.07 (0.05-0.09)
Negative: present 204 (5.0) 107 (6.9) 1.4 (1.1-1.8) .005 0.15 (0.12-0.18)
Target: present 122 (3.0) 30 (2.0) 0.6 (0.4-1.0) .03 0.06 (0.05-0.08)
Structureless areas: present 1934 (47.6) 877 (56.9) 1.5 (1.3-1.6) <.001 0.08 (0.06-0.10)
Hypopigmented areas: present 1244 (30.6) 618 (40.1) 1.5 (1.3-1.7) <.001 0.17 (0.14-0.20)
Blotch
Regular: present 374 (9.2) 67 (4.4) 0.4 (0.3-0.6) <.001 0.08 (0.06-0.10)
Irregular: present 1037 (25.5) 615 (39.9) 1.9 (1.7-2.2) <.001 0.18 (0.14-0.21)
Blue-white veil: present 759 (18.7) 537 (34.9) 2.3 (2.0-2.7) <.001 0.34 (0.30-0.39)
Blue-gray granules: present 348 (8.6) 164 (10.6) 1.3 (1-1.5) .02 0.11 (0.08-0.14)
Scar: present 277 (6.8) 233 (15.1) 2.4 (2.0-2.9) <.001 0.20 (0.16-0.24)
Peripheral brown dots: present 366 (9.0) 195 (12.7) 1.5 (1.2-1.8) <.001 0.04 (0.03-0.06)
Blue-gray dots: present 341 (8.4) 172 (11.2) 1.4 (1.1-1.7) .001 0.16 (0.13-0.19)
Streaks: present 761 (18.7) 402 (26.1) 1.5 (1.3-1.8) <.001 0.21 (0.17-0.24)
Pseudopods: present 296 (7.3) 215 (14.0) 2.1 (1.7-2.5) <.001 0.23 (0.19-0.27)
Structures
White shiny: present 84 (2.1) 78 (5.1) 2.5 (1.8-3.5) <.001 0.16 (0.13-0.19)
Rhomboid: present 74 (1.8) 16 (1.0) 0.6 (0.3-1.0) .04 0.05 (0.03-0.06)
Regression: present 391 (9.6) 275 (17.9) 2.0 (1.7-2.4) <.001 0.11 (0.08-0.13)
Dots
Regular black: present 123 (3.0) 40 (2.6) 0.9 (0.6-1.2) .39 0.05 (0.03-0.07)
Regular brown: present 494 (12.2) 98 (6.4) 0.5 (0.4-0.6) <.001 0.06 (0.04-0.08)
Irregular black: present 392 (9.7) 245 (15.9) 1.8 (1.5-2.1) <.001 0.13 (0.10-0.16)
Irregular brown: present 854 (21.0) 413 (26.8) 1.4 (1.2-1.6) <.001 0.12 (0.09-0.14)
Irregular blue: present 116 (2.9) 65 (4.2) 1.5 (1.1-2.0) .01 0.06 (0.04-0.08)
Irregular red: present 59 (1.5) 34 (2.2) 1.5 (1.0-2.3) .05 0.06 (0.04-0.08)
Globules
Regular black: present 76 (1.9) 33 (2.1) 1.1 (0.8-1.7) .51 0.05 (0.03-0.07)
Regular brown: present 558 (13.7) 121 (7.9) 0.5 (0.4-0.7) <.001 0.17 (0.13-0.20)
Regular blue: present 45 (1.1) 10 (0.7) 0.6 (0.3-1.2) .12 0 (0-0.01)
Irregular black: present 286 (7.0) 191 (12.4) 1.9 (1.5-2.3) <.001 0.14 (0.11-0.17)
Irregular brown: present 786 (19.3) 326 (21.2) 1.1 (1.0-1.3) .13 0.11 (0.08-0.13)
Irregular blue: present 143 (3.5) 113 (7.3) 2.2 (1.7-2.8) <.001 0.07 (0.05-0.09)
Vessels
None 3260 (80.2) 1000 (64.9) 0.5 (0.4-0.5) <.001 0.46 (0.42-0.51)
Comma 236 (5.8) 40 (2.6) 0.4 (0.3-0.6) <.001 0.44 (0.40-0.49)
Atypical 293 (7.2) 293 (19.0) 3.0 (2.5-3.6) <.001 0.26 (0.22-0.30)
Pink veil 251 (6.2) 221 (14.3) 2.5 (2.1-3.1) <.001 0.15 (0.12-0.18)
Polymorphous 115 (2.8) 127 (8.2) 3.1 (2.4-4.0) <.001 0.16 (0.13-0.19)
Abbreviations: ICC, intraclass correlation coefficient; NA, not applicable; OR, odds ratio.
a The ICC (95% CI) values were added as a measure of interobserver agreement.
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Comparison of Diagnostic Accuracy
of the 6 Simplified Algorithms
Measures of diagnostic accuracy for the ABCD rule, the Men-
ziesmethod, the7-point checklist, the3-point checklist, chaos
and clues, andCASHare given inTable 4. Note that this analy-
siswas artificially constructed by using the participants’ con-
sensus evaluation of individual criteria (ie,when ≥50%of the
participants identified adermoscopic feature for a given study
lesion, the attributewas considered present) and that partici-
pantsdidnotdirectly score algorithms inahead-to-headcom-
parison scenario. For these analyses, the data are presented
with defined cut points for melanoma diagnosis. The Men-
zies method had the highest sensitivity for melanoma detec-
tion (95.1%; 95% CI, 89.0%-98.4%), significantly higher than
anyothermethod (P < .001), and the 3-point checklist had the
lowest (68.9%; 95%CI, 59.8%-77.1%). The ABCD rule had the
highest specificity (59.4%; 95%CI, 54.0%-64.6%),whichwas
significantly higher compared with chaos and clues (40.2%;
95%CI, 35.1%-45.5%) and theMenziesmethod,whichhad the
lowest (24.8%;95%CI, 20.1%-30.1%) comparedwithanyother
(P < .001). Chaos and clues had significantly lower specificity
compared with the ABCD rule and the 3- and 7-point check-
lists. TheFigure shows theROCcurves of the6 algorithms.No
significant differences in ROC areas were observed in CASH,
the 7-point checklist, the 3-point checklist, chaos and clues,
andtheABCDrule (P = .44).However, theMenziesmethodhad
a lower ROC area comparedwith CASH, the 7-point checklist,
the3-point checklist, theABCDrule, andchaosandclues,with
Pvalues for each comparisonof .03, .03, .007, .001, and<.001,
respectively.
Discussion
In this study, which involved participants of varied back-
grounds who reported comfort with and regular use of der-
moscopy, we revalidated the diagnostic importance of
well-described criteria associated with melanoma, such as
atypical network, irregular blotch, regression, streaks, pseu-
dopods, atypical dots or globules, atypical vessels, any blue
or white color, and blue-white veil. However, we found that
these criteria had poor to fair levels of interobserver agree-
ment. Criteriawith thehighest levels of discriminatorypower
and interobserver agreement included features not always
highlighted in existing algorithms, suchas commavessels and
absence of vessels, as well as subjective features that quan-
tify the overall organization of a lesion, namely, architectural
disorder and symmetry of pattern and contour. We further
found that6simplifieddermoscopyalgorithmshadsimilarbut
modest levels of diagnostic accuracy.
Few reproducibility studies of dermoscopic features have
been performed, particularly investigating the discriminatory
power and interobserver and intraobserver agreement of spe-
cific criteria.An Internet consensusmeetingofdermoscopyex-
perts in 2003 found that pattern analysis, the ABCD rule, the
7-point checklist, and theMenziesmethod all have high sensi-
tivity and specificity for the diagnosis of melanoma.11 How-
ever, theinterobserveragreementofthediagnosticmethodswas
moderate, andmany individualdiagnostic structureshadpoor
levels of interobserver agreement. The authors suggested that
thisdiscrepancymightbeattributable to the importanceof the
overall dermoscopic gestalt of a given lesion to the assignment
of a final diagnosis, independent of the recognition of indi-
vidual criteria.11 Indeed, experts usually do not apply algo-
rithms. Inotherwords,evaluatorsmayassignadiagnosisbased
on the overall impression of a lesion and then search for crite-
ria to fit their decision. To avoid this potential bias, partici-
pants in our study evaluated the presence and absence of der-
moscopic features but did not apply an algorithm or make a
diagnosis. A comparative study8 of pattern analysis and the
different algorithms among nonexperts have also found gen-
erally poor interobserver agreement for most individual der-
moscopic criteria but much better results for the method as a
whole. This interpretation is supported by a study12 of derma-
tologyresidents that foundthatpatternanalysis,definedbythe
authorsasthe“simultaneousassessmentof thediagnosticvalue
of all dermoscopy features shown by the lesion,”12(p 981) had a
higherdiagnosticaccuracycomparedwiththeABCDruleofder-
moscopy and the 7-point checklist.
Of interest, in the present study, several features that in-
dicate overall organization and symmetry had the highest
agreementanddiscriminatorypower, suchasarchitecturaldis-
order, contour asymmetry, and dermoscopic pattern asym-
metry. These concepts have previously been summarized as
disarrangement in appearance or chaos and support the use-
fulness of chaos and clues7 and the 3-point checklist,13 which
were created for use in melanocytic and nonmelanocytic le-
sions. Reassuringly, well-designed, prospective clinical
studies7,8,14,15 have found that use of dermoscopy signifi-
cantly improves the ability of general practitioners to evalu-
ate pigmented lesions in theprimary care setting. Indeed, the
3-point checklist was tested in a clinical setting and allowed
Table 4. Measures of Diagnostic Accuracy for 6 Dermascopic Algorithms
Measure
7-Point Checklist
(Cut Point ≥3)
CASH
(Cut Point ≥6)
Menzies
Method
ABCD Rule
(TDS Score >4.75)
3-Point
Checklist
Chaos
and Clues
Sensitivity, % (95% CI) 70.6 (61.5-78.6) 77.9 (69.7-85.1) 95.1 (89.0-98.4)a 74.8 (66.0-82.3) 68.9 (59.8-77.1) 82.4 (66.1-96.5)
Specificity, % (95% CI) 57.5 (52.2-62.7) 50.9 (45.4-56.4) 24.8 (20.1-30.1)b 59.4 (54.0-64.6) 58.7 (53.4-63.8) 40.2 (35.1-45.5)c
ROC area (95% CI) 0.65 (0.59-0.69) 0.65 (0.59-0.69) 0.60 (0.57-0.63) 0.66 (0.62-0.72) 0.64 (0.59-0.69) 0.66 (0.63-0.70)
Abbreviations: CASH, color, architecture, symmetry, and homogeneity; ROC,
receiver operating characteristic; TDS, total dermatoscopy score.
a Sensitivity of theMenzies method was significantly higher than any other
algorithm.
b Specificity of theMenzies method was significantly lower than any other
algorithm.
c Specificity of chaos and clues was significantly lower than the 7-point
checklist, the 3-point checklist, and the ABCD rule.
Research Original Investigation Dermoscopic Criteria Used to Differentiate Nevi FromMelanoma
804 JAMADermatology July 2016 Volume 152, Number 7 (Reprinted) jamadermatology.com
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/derm/935431/ by a Universidad de Barcelona User  on 05/29/2017
Copyright 2016 American Medical Association. All rights reserved.
primary care physicians to perform25.1%better triage of skin
lesions suggestiveof skin cancer comparedwithnaked-eyeex-
amination alone.14 However, it remains unknown how gen-
eral practitioners or novices rely on overall dermoscopic ge-
stalt vs application of a dermoscopic algorithm when using
dermoscopy in thedaily clinical setting. Tomore broadly pro-
mote the use of dermoscopy in the primary care setting, our
results suggest that significant efforts areneeded to standard-
ize and improvedermoscopic terminology,which is oneof the
central goals of the International Skin Imaging Collaboration
Melanoma Project.16,17
Ourdata suggest that features that quantify theoverall or-
ganization of a lesion (eg, architectural disorder and pattern
asymmetry)havehigher levelsof interobserveragreementand
discriminatory power than many well-known dermoscopic
structures (eg, atypical network or irregular blotch); thus, cri-
teria for overall organization of a lesion may not be suffi-
ciently emphasized in dermoscopic algorithms for mela-
noma diagnosis. Specific dermoscopic structures with low
prevalence, such as negative network,may still be robust cri-
teria formelanomadiagnosis buthadpoor agreement and low
discriminatory power in this study because participants may
have received insufficient training toaccurately identify them.
Accordingly, criteria that are useful in melanoma diagnosis
should not be abandoned but rather readdressed and poten-
tially refined through further study. This point also high-
lights the evolving nature and current lack of standardization
ofdermoscopy teachingworldwideand thecritical need tode-
termine effective teaching methods of dermoscopy.
Several factors may contribute to the poor interobserver
agreement levelsobserved in this study.First, participantsmay
not have received sufficient training in the definitions of crite-
ria or, despite training, they used different definitions of crite-
ria,potentially influencedbytheirpersonalexperiencewithder-
moscopy. To help mitigate these potential factors, we created
algorithmtutorialswithdefinitionsofcriteria.However,comple-
tionof tutorialswasnot required forparticipation. Second, the
interobserver agreement levelsmay reflect the range of exper-
tise levels of participants in that certain criteria require signifi-
cant training formastery. Third, a participant’s gestalt diagno-
sis of a lesionmay have affected their criteria selection; if so, a
participantmayhavepreferentially assigned somecriteria and
ignored others. Lastly, criteriamay simply be inherently unre-
liable. For this point, it is important to recognize that tests in
medicine are frequently subject to limitations in human judg-
ment and generally do not exceed fair levels of interobserver
agreement. In addition, interpretation of the ICC as levels of
agreement among reviewers has limitations. When the ICC is
high,we canbe assured that the agreement level for a givenat-
tribute isgood.However, a lowICCmaybeattributable toasub-
optimallydesignedevaluationprocess.Forexample,small tech-
nical differences in imaging, such as variations in focus or
contrast, canhave largeeffectsonmeasureofagreement. Inad-
dition, evaluations were performed online, and users viewed
imagesundernoncalibratedconditions (eg, variable imagedis-
playmonitors and room lighting).
Therearemultiple limitationsof this study.First, therewas
a relatively low rate of study completion with likely participa-
tion bias formore experienced dermoscopists. As a result, our
results may not be generalizable to beginners. Second, we as-
sessed diagnostic accuracy through the artificial scenario of a
readerstudy,whichmaynotberepresentativeofdecisionsmade
during livepatient examinations.Third, the imagedata setwas
not representative of the entire spectrum of melanocytic le-
sions because it excluded facial, acral, and amelanotic lesions
andwas biased toward diagnostically challenging lesionswith
few banal nevi included. In addition, nonmelanocytic lesions
were excluded, and the study assumes that participants
would apply these criteria after reliably identifying lesions as
melanocytic in origin (ie, 2-step algorithm). Thus, compari-
son of measures of diagnostic accuracy for the included algo-
rithms may not accurately reflect real-life sensitivities and
specificities. Finally, diagnostic performance of algorithms
was assessed based on consensus evaluations (≥50%) for
individual criteria and not directly by individual participants
or experts.
Conclusions
Algorithms are generally well accepted to be helpful in train-
ing novices in discriminating processes. Therefore, the crite-
ria of an ideal algorithm should be easy to learn, valid, and re-
liable. Unfortunately, to our knowledge, no dermoscopic
algorithm has emerged with these characteristics for mela-
noma recognition.Our results confirm theneed to further im-
prove dermoscopic terminology, criteria, and algorithms. To
doso, future studiesmaybenefit fromcrowd-sourcingandcol-
lective intelligence approaches,18 as well as the public image
archive being created in the International Skin Imaging
Figure. Comparison of the Diagnostic Accuracy of the Dermoscopic
Algorithms
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CollaborationMelanoma Project, which permits analysis and
comparisonof theareaswithina lesion thatusers select ashav-
ing unique dermoscopic structures.16,17 We hope these ef-
forts will lead to a unified dermoscopy algorithm, automated
detectionof criteria, andclinicaldecisionsupport systems that
facilitate population-based melanoma screening efforts.19
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